Drug Safety Studies May Hide Real Risks, New Research Warns

A pharmacoepidemiological study reveals that a common research method used to evaluate drug safety can actually mask dangerous side effects rather than catch them. The finding threatens the reliability of post-market drug monitoring and could force regulators and pharmaceutical companies to reconsider how they track medication risks after approval.

Originaltitel: Bias amplification of unobserved confounding in pharmacoepidemiological studies using indication-based sampling